An epidemiology-based model as a tool to monitor the outbreak of inappropriateness in tumor marker requests: A national scale study

Clinical Chemistry and Laboratory Medicine

Volumn 54, Issue 3, 2016, Pages 473-482

  Gion, Massimo ^a   Peloso, Lucia ^a   Trevisiol, Chiara ^b   Squarcina, Elisa ^a   Zappa, Marco ^c   Fabricio, Aline S C ^a  

^a Ospedale Civile   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

appropriateness; biomarkers; epidemiology; oncology; prevalence

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ARTICLE; BILIARY TRACT CANCER; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CLINICAL PRACTICE; DIAGNOSTIC ERROR; ENDOMETRIUM CANCER; FEMALE; HEALTH CARE; HUMAN; LABORATORY TEST; LIFESPAN; MALE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; CLINICAL STUDY; ECONOMICS; EPIDEMIOLOGY; HEALTH SERVICE; ITALY; LABORATORY TECHNIQUE; PREVENTION AND CONTROL; PROCEDURES; THEORETICAL MODEL; TRENDS; UTILIZATION;

BIOMARKERS, TUMOR; CLINICAL LABORATORY TECHNIQUES; CLINICAL STUDIES AS TOPIC; EPIDEMIOLOGIC METHODS; HUMANS; ITALY; MEDICAL OVERUSE; MODELS, THEORETICAL;

EID: 84958762502     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0329     Document Type: Article

References (34)

1. Smellie WS. Demand management and test request rationalization. Ann Clin Biochem 2012;49:323-36.
2. Fryer AA, Hanna FW. Managing demand for pathology tests: financial imperative or duty of care? Ann Clin Biochem 2009;46:435-7.
3. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. Br Med J 2012;344:e3502.
4. Welch G, Schwartz L, Woloshin S. Overdiagnosed: making people sick in pursuit of health. Boston: Beacon Press, 2011.
5. van Walraven C, Naylor CD. Toward optimal laboratory use. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. J Am Med Assoc 1998;280:550-8.
6. Zhi M, Ding EL, Theisen-Toupal J, Whelan J, Arnaout R. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One 2013;8:e78962.
7. Hauser RG, Shirts BH. Do we now know what inappropriate laboratory utilization is? An expanded systematic review of laboratory clinical audits. Am J Clin Pathol 2014;141:774-83.
8. Fryer AA, Smellie WS. Managing demand for laboratory tests: a laboratory toolkit. J Clin Pathol 2013;66:62-72.
9. Janssens PM. Managing the demand for laboratory testing: options and opportunities. Clin Chim Acta 2010;411:1596-602.
10. Salinas M, López-Garrigós M, Uris J, Leiva-Salinas C; Appropriate Utilization of Laboratory Tests (REDCONLAB) working group. A study of the differences in the request of glycated hemoglobin in primary care in Spain: a global, significant, and potentially dangerous under-request. Clin Biochem 2014;47:1104-7.
11. Sood R, Sood A, Ghosh AK. Non-evidence-based variables affecting physicians' test-ordering tendencies: a systematic review. Neth J Med 2007;65:167-77.
12. Solomon DH, Hashimoto H, Daltroy L, Liang MH. Techniques to improve physicians' use of diagnostic tests: a new conceptual framework. J Am Med Assoc 1998;280:2020-7.
13. Bunting PS, Van Walraven C. Effect of a controlled feedback intervention on laboratory test ordering by community physicians. Clin Chem 2004;50:321-6.
14. Bell DS, Harless CE, Higa JK, Bjork EL, Bjork RA, Bazargan M, et al. Knowledge retention after an online tutorial: a randomized educational experiment among resident physicians. J Gen Intern Med 2008;23:1164-71.
15. Baird G. The laboratory test utilization management toolbox. Biochem Med (Zagreb) 2014;24:223-34.
16. Salinas M, López-Garrigós M, Asencio A, Leiva-Salinas M, Lugo J, Leiva-Salinas C. Laboratory utilization improvement through a computer-aided algorithm developed with general practitioners. Clin Chem Lab Med 2014;53:1391-7.
17. Gion M, Franceschini R, Rosin C, Trevisiol C, Peloso L, Zappa M, et al. An epidemiology-based model to estimate the rate of inappropriateness of tumor marker requests. Clin Chem Lab Med 2014;52:889-97.
18. World Health Organization. International statistical classification of diseases and related health problems, Tenth revision. Geneva: World Health Organization (WHO), 1992.
19. AIRTUM working group. Italian cancer figures, report 2010: cancer prevalence in Italy; Patients living with cancer, long-term survivors and cured patients. Epidemiol Prev 2010;34(Suppl):S1-188.
20. Scottish Intercollegiate Guidelines Network (SIGN). Management of epithelial ovarian cancer. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN), 2013.
21. Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:961-5.
22. National Collaborating Centre for Cancer. Early and locally advanced breast cancer: diagnosis and treatment. London: National Institute for Health and Clinical Excellence (NICE), 2009.
23. Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol 2013;24:1434-43.
24. Jewell NP. Statistics for epidemiology. New York: Chapman & Hall, 2003.
25. Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer, 2009.
26. Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 2013;31:4465-70.
27. National Institute for Health and Clinical Excellence (NICE). Colorectal cancer. The diagnosis and management of colorectal cancer. London: National Institute for Health and Clinical Excellence (NICE), 2011.
28. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313-27.
29. Alexander B. Reducing healthcare costs through appropriate test utilization. Critical Values 2012;5:6-8.
30. Kwok J, Jones B. Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory. J Clin Pathol 2005;58:457-62.
31. Salinas M, López-Garrigós M, Díaz J, Ortuño M, Yago M, Laíz B, et al. Regional variations in test requiring patterns of general practitioners in Spain. Ups J Med Sci 2011;116:247-51.
32. Mogyorosy Z, Mogyorosy G. Practice pattern and geographic variation in test ordering: a literature review. Orv Hetil 2006;147:25-31.
33. Larsson A, Palmer M, Hulten G, Tryding N. Large differences in laboratory utilisation between hospitals in Sweden. Clin Chem Lab Med 2000;38:383-9.
34. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JA, Burney PG, Donner A. Methods in health service research. Evaluation of health interventions at area and organisation level. Br Med J 1999;319:376-9.